Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Calls For Single Conformity Assessments To Cover EU MDR, EHDS And AI Act

Executive Summary

Who should be responsible for conducting conformity assessments for medical devices in the context of the digital and data laws that sit alongside the EU MDR and IVDR? MedTech Europe says manufacturers should be able to follow a single conformity assessment route where possible.

You may also be interested in...



EU Digital Tech Trade Body Weighs In On Medical Device ‘Over-Regulation’ Risk

While the European Health Data Space and its objectives should be a positive regulatory development for the EU health sector, DIGITALEUROPE stresses that the risk of counterproductive conflicts with other proposed laws around AI and data must be addressed.

Cybersecurity In The EU: How Overlapping Regulations Could Harm Medtech

Overlapping EU regulations that relate to medical devices and cybersecurity have been a concern among industry for many months. Medtech Insight asks an expert where, how and why overlap could prove troublesome.

EU Regulatory Roundup, May 2023: MDR Extension Updates Resume

May saw a resurgence of EU MDR news, following a few quieter weeks. Guidance on demonstrating compliance with extended transition periods and compiling clinical investigation reports were among the top-read articles in Medtech Insight in the past month.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel